Newswise — FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®) is collaborating with National Decision Support Company (NDSC) to integrate the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) into NDSC’s CareSelect Imaging to allow for access to imaging recommendations, adapted from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).
“Through our collaboration with NDSC, providers and their patients with cancer can benefit from access to NCCN Guidelines-based, qualified imaging criteria incorporated directly into electronic health care workflow,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “We are grateful to NDSC for their willingness to be an NCCN Health Information Technology (HIT) licensee; providing NCCN Imaging AUC at point-of-care through technology helps assure quality cancer care while minimizing unneeded or inappropriate imaging.”
Adapted from the NCCN Guidelines®, NCCN Imaging AUC™ support clinical decision-making around the use of imaging in patients with cancer by outlining all imaging procedures recommended in the NCCN Guidelines, including radiographs, computed tomography (CT) scans, magnetic resonance imaging (MRI), functional nuclear medicine imaging (PET, SPECT), and ultrasound. NCCN is recognized by Centers for Medicare & Medicaid Services (CMS) as an approved provider-led entity (PLE) for development of imaging AUC.
“NDSC’s collaboration with NCCN expands on the more than 15,000 clinical endpoints already contained in our solution, installed at more than 150 health systems nationally,” said Michael Mardini, Chief Executive Officer, National Decision Support Company. “The robust NCCN criteria sets the standard for imaging appropriate use criteria for cancer patients. Our relationship with NCCN will enable NDSC to apply our proven competence to deliver guidelines into EMR workflows and enable us to provide a comprehensive cancer AUC set consistent with our mission to deliver standard-based, nationally recognized guidelines at the point of care.”
A clinical decision support solution from NDSC, CareSelect Imaging leverages the ACRselect Technology Platform to deliver a comprehensive range of AUC for diagnostic imaging. Within the system, AUC is sourced from approved PLEs, including the American College of Radiology, the American College of Cardiology, and NCCN. CareSelect delivers AUC directly into the electronic health record (EHR) workflow to provide real-time support that is actionable and compliant with Protecting Access to Medicare Act (PAMA).
NCCN Imaging AUC™ are currently available for 12 NCCN Guidelines; NCCN Imaging AUC™ are expected to be integrated into CareSelect Imaging beginning in the third-quarter of 2016.
More information about NCCN Imaging AUC™ is available at NCCN.org/ImagingAUC.
About National Decision Support CompanyNational Decision Support Company provides enterprise wide Clinical Decision Support solutions that enable more efficient and appropriate care, improve population health, and save money. Our technology platform converts published guidelines from credible, compliant content sources into actionable decision support criteria delivered directly into the EMR workflow.
About the National Comprehensive Cancer NetworkThe National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; University of Wisconsin Carbone Cancer Center, Madison, WI; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.